• 5297 Citations
  • 33 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Cytokine-Induced Killer Cells Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Indoleamine-Pyrrole 2,3,-Dioxygenase Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 5297 Citations
  • 33 h-Index
  • 243 Article
  • 27 Review article
  • 7 Short survey
  • 3 Letter

A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity

Liu, M., Sun, Q., Wang, J., Wei, F., Yang, L. & Ren, X., Jun 15 2019, In : International Journal of Cancer. 144, 12, p. 2909-2917 9 p.

Research output: Contribution to journalReview article

Tumor Microenvironment

Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial

Zhou, A. P., Bai, Y., Song, Y., Luo, H., Ren, X., Wang, X., Shi, B., Fu, C., Cheng, Y., Liu, J., Qin, S., Li, J., Li, H., Bai, X., Ye, D., Wang, J. & Ma, J., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Renal Cell Carcinoma
Randomized Controlled Trials

Chemoradiotherapy-induced CD4+and CD8+T-Cell alterations to predict patient outcomes in esophageal squamous cell carcinoma

Chen, X., Zhang, W., Qian, D., Guan, Y., Wang, Y., Zhang, H., Er, P., Yan, C., Li, Y., Ren, X., Pang, Q. & Wang, P., Jan 1 2019, In : Frontiers in Oncology. 9, FEB, 00073.

Research output: Contribution to journalArticle

Open Access
Disease-Free Survival
Lymphocyte Subsets

Clinical significance of serum Type III interferons in patients with gastric cancer

Zhao, H., Dong, N., Liu, T., Zhang, P., Zheng, Y., Yang, L. & Ren, X., Mar 1 2019, In : Journal of Interferon and Cytokine Research. 39, 3, p. 155-163 9 p.

Research output: Contribution to journalArticle

Stomach Neoplasms

Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin ® -activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancer

Zhao, L., Li, T., Yang, Y., Zhang, Y., Li, W., Han, L., Shang, Y., Lin, H., Ren, X. & Gao, Q., Mar 1 2019, In : Immunotherapy. 11, 4, p. 273-282 10 p.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells
Cell- and Tissue-Based Therapy
Non-Small Cell Lung Carcinoma